Este articulo discute lo que usted necesita saber luego de que se le haya implantado un DCI. No todos los DCI son iguales. Esto puede permitir que otros proveedores revisen el dispositivo para ver si funciona correctamente. Durante 4 a 6 semanas, NO levante el brazo por encima del hombro en el lado del cuerpo donde le colocaron el DCI. Hay algunos dispositivos que usted debe mantener por lo menos a 12 pulgadas
|Published (Last):||1 April 2005|
|PDF File Size:||5.73 Mb|
|ePub File Size:||9.42 Mb|
|Price:||Free* [*Free Regsitration Required]|
Introduction: The use of an implantable cardioverter-defibrillator reduces the probability of sudden cardiac death in patients with heart failure.
Materials and methods: We developed a Markov model including costs, effectiveness, and quality of life from the perspective of the Colombian health system. The transition probabilities were obtained from a systematic review of the literature. The outcome used was the quality-adjusted life years. We calculated the costs by consulting with the manufacturers of the device offered in the Colombian market and using national-level pricing manuals.
We conducted probabilistic and deterministic sensitivity analyses. However, the result may change according to the time horizon, the probability of death, and the price of the device. Conclusions: The use of an implantable cardioverter-defibrillator for preventing sudden cardiac death in patients with heart failure would be a cost-effective strategy for Colombia. The results should be examined considering the uncertainty.
Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. Search: Search. Advanced Clipboard. Create file Cancel.
Email citation To:. Format: Summary Summary text Abstract Abstract text. Send email Cancel. Add to Collections Create a new collection Add to an existing collection. Name your collection: Name must be less than characters.
Choose a collection: Unable to load your collection due to an error Please try again. Add Cancel. Add to My Bibliography My Bibliography. Unable to load your delegates due to an error Please try again.
Your saved search Name of saved search:. Search terms:. Test search terms. Would you like email updates of new search results? Email: change. Frequency: Monthly Weekly Daily.
Which day? Send at most: 1 item 5 items 10 items 20 items 50 items items items. Send even when there aren't any new results. Optional text in email:. Save Cancel. Create a file for external citation management software Create file Cancel. Full-text links Cite Favorites. Abstract in English , Spanish.
Woo CY, et al. Ann Intern Med. PMID: The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Yao G, et al. Eur Heart J.
Epub Nov Cost-effectiveness of implantable cardioverter-defibrillators in Brazil: primary prevention analysis in the public sector. Ribeiro RA, et al. Value Health. Epub Sep 2. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation biventricular pacing for heart failure: systematic review and economic model.
Fox M, et al. Health Technol Assess. PMID: Review. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
Colquitt JL, et al. Show more similar articles See all similar articles. MeSH terms Colombia Actions. Cost-Benefit Analysis Actions. Decision Trees Actions. Humans Actions. Meta-Analysis as Topic Actions. Middle Aged Actions. Quality of Life Actions. Systematic Reviews as Topic Actions. Time Factors Actions.
Full-text links [x] Colombian National Health Institute. Copy Download.
Alta tras colocación de desfibrilador cardioversor implantable
Introduction: The use of an implantable cardioverter-defibrillator reduces the probability of sudden cardiac death in patients with heart failure. Materials and methods: We developed a Markov model including costs, effectiveness, and quality of life from the perspective of the Colombian health system. The transition probabilities were obtained from a systematic review of the literature. The outcome used was the quality-adjusted life years.
An implantable cardioverter-defibrillator ICD or automated implantable cardioverter defibrillator AICD is a device implantable inside the body, able to perform cardioversion , defibrillation , and in modern versions pacing of the heart. The device is therefore capable of correcting most life-threatening cardiac arrhythmias. The ICD is the first-line treatment and prophylactic therapy for patients at risk for sudden cardiac death due to ventricular fibrillation and ventricular tachycardia. Current device batteries last about 6—10 years, With advances in the technology batteries with more capacity or, potentially in the future with rechargeable batteries   it may be possible to increase this well past 10 years. The lead the electrical cable connecting the device to the heart has a much longer average longevity but can incur various types of malfunction, specifically insulation failure or fracture of the conductor and require replacement.